Navigation Links
WuXi PharmaTech Schedules 2007 Third Quarter Earnings Release on Monday, November 12, 2007

Earnings Conference Call to be held on November 13, 2007 at 8:00 am

(Eastern) / 5:00 am (Pacific) / 9:00 pm (Beijing/Hong Kong)

SHANGHAI, China, Oct. 23 /Xinhua-PRNewswire/ - WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech" or "the Company"), the leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it will release unaudited financial results for the third quarter ended September 30, 2007 after the US market closes on Monday, November 12, 2007.

The earnings release will be available on the investor relations page of its website at

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (Eastern) / 5:00 am (Pacific) / 9:00 pm (Beijing/Hong Kong) on Tuesday, November 13, 2007 to discuss its 2007 third quarter financial results and recent business activity. The conference call may be accessed by calling:

Toll Free Toll

United States +1-866-316-1369 +1-913-981-4915

China, Northern Region +10-800-714-0970

China, Southern Region +10-800-140-0945

Hong Kong +800-965-503

United Kingdom +0-800-051-7166

A telephone replay will be available shortly after the call until December 12, 2007 at (US) +1-888-203-1112/ (UK) +0-808-101-1153 / (HK) +800-901-108. Passcode: 7947278.

A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at

About WuXi PharmaTech

Founded in 2000, Shanghai-based WuXi PharmaTech is the leading China-based pharmaceutical and biotechnology R&D outsourcing company. As a research- driven and customer-focused company, WuXi PharmaTech provides pharmaceutical and biotechnology companies a broad and integrated portfolio of laboratory and research manufacturing services throughout the drug discovery and development process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions that save its customers both time and money. Its operations are grouped into two segments: laboratory services, consisting of discovery chemistry, service biology, analytical, pharmaceutical development and process development services, and manufacturing, focusing on manufacturing of advanced intermediates and active pharmaceutical ingredients for R&D use. In 2006, WuXi PharmaTech provided services to 70 pharmaceutical and biotechnology customers, including nine of the top ten pharmaceutical companies in the world, as measured by 2006 total revenues. For more information, please visit:

For more information, please contact:

Investor Contact:

Dr. Hai MiVice

President, Corporate Communications

WuXi PharmaTech Co., Ltd

Tel: +86-21-5046-3726


Investor Relations (US):

Mahmoud Siddig


Taylor Rafferty

Tel: +1-212-889-4350


Investor Relations (HK):

Ruby Yim

Managing Director

Taylor Rafferty

Tel: +852-3196-3712


Media Contact:

John Dooley

Taylor Rafferty

Tel: +1-212-889-4350


SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Shorter Radiation Schedules Found To Be More Effective For Patients With Breast Cancer
2. Vaccination Schedules Rates among Canadian Kids Dip Low
3. UP Government Fixes Work Schedules for Provincial Medical Service Doctors
4. Third artificial heart patient introduced
5. Extra hormone found to cut appetite by a third
6. Third generation Small pox vaccine from Cell-culture
7. Surgery Offers Better Treatment For Third Degree Piles
8. One Third Of All Cancers Preventable!
9. Britain Announces Third Transfusion Related Mad Cow Case
10. Kleins Third Way Has Tough Opposition
11. Ignorance about AIDS rampart in Third of College Students: Chinese survey
Post Your Comments:
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... Silver Spring, Md (PRWEB) , ... November 25, ... ... the Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups ... the history of this disease. The Periwinkle Pioneers, nominated by the public, will ...
(Date:11/25/2015)... ... November 25, 2015 , ... Many people know of the ... gain, cold hands, and dry skin. But many people who find their cholesterol levels ... regimen instead of their thyroid, especially if they don’t have any of the other ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion Bootie , ... early celebration of the early holiday shopping season. Starting Wednesday November 25th, Bunion ... ea). Black Friday promotional pricing is in addition to any automatic discounts applied ...
(Date:11/24/2015)... ... , ... New patients who wish to seek treatment for missing teeth can ... her Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 ... Missing teeth can lead to a variety of complications if they are not replaced ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... Investors"), pursuant to which BioLight and the New Investors ... Ltd. subsidiary ("IOPtima") via a private placement. The financing ... its innovative IOPtimate™ system used in the treatment of ... pathway process for the IOPtimate™ system with the U.S. ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 Research ... of the "Membranes Market - Global Forecast to ... Asia-Pacific , accounting for 37.21% of the ... Asia-Pacific region is projected to ... This growth has been attributed primarily to the fast ...
(Date:11/24/2015)... WuXi PharmaTech (Cayman) Inc. ("WuXi" or the "Company") (NYSE: ... technology platform company serving the pharmaceutical, biotechnology, and medical ... and the United States , ... shareholders held today, the Company,s shareholders voted in favor ... announced agreement and plan of merger (the "Merger Agreement") ...
Breaking Medicine Technology: